Detalhe da pesquisa
1.
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer.
Proc Natl Acad Sci U S A
; 120(4): e2218118120, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652476
2.
EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner.
Proc Natl Acad Sci U S A
; 118(30)2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301901
3.
KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining Golgi complex integrity.
Proc Natl Acad Sci U S A
; 117(22): 12341-12351, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430335
4.
Epigenetic regulation and targeting of ECM for cancer therapy.
Am J Physiol Cell Physiol
; 322(4): C762-C768, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235427
5.
Loss of BOP1 confers resistance to BRAF kinase inhibitors in melanoma by activating MAP kinase pathway.
Proc Natl Acad Sci U S A
; 116(10): 4583-4591, 2019 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782837
6.
70S-scanning initiation is a novel and frequent initiation mode of ribosomal translation in bacteria.
Proc Natl Acad Sci U S A
; 113(9): E1180-9, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26888283
7.
Interleukin 8 is a biomarker of telomerase inhibition in cancer cells.
BMC Cancer
; 18(1): 730, 2018 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29986697
8.
LKB1 preserves genome integrity by stimulating BRCA1 expression.
Nucleic Acids Res
; 43(1): 259-71, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488815
9.
Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A.
Proc Natl Acad Sci U S A
; 111(30): E3062-71, 2014 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25024194
10.
Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma.
Int J Mol Sci
; 18(6)2017 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28556791
11.
Negative pressure wound therapy in the treatment of ulcerated infantile haemangioma.
Pediatr Surg Int
; 31(7): 653-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25966985
12.
Roles and therapeutic targeting of ceramide metabolism in cancer.
Mol Metab
; 83: 101936, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599378
13.
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models.
iScience
; 27(5): 109800, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38741708
14.
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE.
Cell Death Dis
; 14(7): 456, 2023 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37479754
15.
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B.
Cell Rep Med
; 4(11): 101285, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951219
16.
Transcriptional determinants of cancer immunotherapy response and resistance.
Trends Cancer
; 8(5): 404-415, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35125331
17.
Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor-resistant pancreatic ductal adenocarcinoma.
Front Oncol
; 12: 926437, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35982980
18.
Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth.
iScience
; 25(8): 104752, 2022 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35942091
19.
Changes in the Transcriptome and Chromatin Landscape in BRAFi-Resistant Melanoma Cells.
Front Oncol
; 12: 937831, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35785205
20.
Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis.
iScience
; 25(5): 104211, 2022 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35494243